Narula Sanjeev sold PHAT

October 6, 2026 · Form 4 insider transaction

Narula Sanjeev sold 13,485 shares of Phathom Pharmaceuticals, Inc. at $6.78 per share, a transaction worth $91.4K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
13,485
Price
$6.78
Total value
$91.4K
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateOctober 6, 2026
Filing dateOctober 8, 2026
Shares owned after214,718
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation.; Includes 1,488 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2026.

View the original Form 4 on SEC EDGAR